TSX closed
Loading markets…

Advertisement

Stocks/NASDAQ/RVMD

Revolution Medicines Inc (RVMD : NASDAQ)

Common Stock

$182.15

USD

+4.19 (2.35%)

Last updated: 2026-10-19

Follow RVMD

RVMD

Revolution Medicines Inc

Source:WealthAwesomeWealthAwesome
↓ $25.17 (-12.14%)
30 day period
$177.96$192.82$207.68Sep 8Sep 29Oct 19

Performance

1 Day

+2.35%

1 Week

-6.08%

1 Month

-4.61%

YTD

+130.51%

Key Statistics

Market Cap

$39.04B

52W High

$224.31

52W Low

$52.48

P/E Ratio

-

50 Day MA

$203.12

200 Day MA

$151.62

Beta

1.40

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/19/2026$179.98$183.87$177.00$182.15$182.151,978,993
10/16/2026$188.86$189.68$175.91$177.96$177.962,973,600
10/15/2026$193.31$195.94$189.14$189.26$189.261,568,008
10/14/2026$186.84$197.00$185.88$193.52$193.522,463,046
10/13/2026$191.57$193.61$187.14$188.44$188.442,939,058
10/12/2026$187.79$194.26$184.76$193.95$193.951,667,288
10/9/2026$186.01$193.50$184.37$189.76$189.762,210,300
10/8/2026$198.51$199.64$180.49$188.12$188.124,855,046
10/7/2026$198.18$203.50$196.25$200.87$200.871,185,197
10/6/2026$208.57$208.57$195.00$199.87$199.871,631,360

Analyst Price Targets

Based on 24 analysts covering RVMD · as of Oct 20, 2026

📈

Wall Street analysts forecast RVMD stock price to rise 41.6% over the next 12 months.

Consensus

Strong Buy

4.71 / 5.00

Avg. Target

US$257.84

+41.6% Upside

Previously US$257.80 on Oct 19, 2026

Current Price

US$182.15

Last close

Analyst Breakdown (24 analysts)

Strong Buy 18
Buy 5
Hold 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on RVMD's historical volatility

HistoricalForecast68%95%
US$102.41US$139.67US$176.92US$214.18US$251.44US$288.70TodayJun 11Aug 17Oct 19Dec 1Jan 14Feb 26

30-Day Vol

40.8%

Annualized

90-Day Vol

40.0%

Annualized

Trend (90d)

-16.0%

Annualized drift

90d Mean

US$172.02

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$178.71US$155.22 – US$205.76
60 trading daysUS$175.33US$143.65 – US$214.01
90 trading daysUS$172.02US$134.77 – US$219.58

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Financials

Revenue (TTM)
$742,000
EBITDA
$-1.62B
Profit Margin
0.00%
ROE (TTM)
-79.09%
EPS (Diluted)
-8.87
Book Value
12.16

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About RVMD.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
FRGTFreight Technologies Inc$1.47+97900.00%
GPGreenPower Motor Company Inc$1.46+11217.83%
MBRXMoleculin Biotech Inc$5.26+1775.89%
REVBRevelation Biosciences Inc$3.29+577.76%
SLNSilence Therapeutics PLC$19.58+125.58%
SXTCChina SXT Pharmaceuticals Inc$0.11+71.08%
AFJKRAimei Health Technology Co., Ltd Right$0.14+64.47%
XHGXChange TEC.INC$3.20+60.00%

RVMD.US news timeline

4 articles covering RVMD.US, most recent first

Latest

Revolution Medicines’ Positive CHMP Opinion: What Investors Should Know

•Stocks

Advertisement